* [SUP-ICU](https://www.nejm.org/doi/full/10.1056/NEJMoa1714919) (2018)
	* ~3300 adult non-pregnant Europeans admitted to ICU with some risk of GIB, no active GIB or transplant, and for active treatment
	* Block randomised trial of 40mg pantoprazole OD vs. placebo
	* No change in 90 day mortality (31.1% vs 30.4%)
	* Secondary outcomes:
		* Significant â†“ in clinically important GIB (2.5% vs 4.2%)
		* No change in VAP, *C. difficile* infection, or other SAE